Resmed Inc (N:RMD)

Business Focus: Advanced Medical Equipment & Technology

Apr 25, 2024 04:05 pm ET
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2024. Third Quarter 2024 HighlightsAll comparisons are to the prior year period Revenue increased by 7% to $1.2 billion; up 7% on a constant...
Apr 04, 2024 04:05 pm ET
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on Thursday, April 25, 2024, after the New York Stock Exchange closes. Following the release, ResMed...
Mar 15, 2024 03:05 am ET
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
ResMed (NYSE: RMD, ASX: RMD), the global leader in digital health and cloud-connected medical devices that transform care for people with sleep apnea, COPD, and other chronic diseases, today announced the results of its 2024 Global Sleep Survey in...
Mar 06, 2024 09:05 am ET
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
ResMed (NYSE: RMD, ASX: RMD), a global leader in digital health and cloud-connected medical devices that transform care for people with sleep apnea and other chronic respiratory diseases, today announced the U.S. launch of the AirFit F40, an...
Feb 12, 2024 04:16 pm ET
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep A
ResMed (NYSE: RMD, ASX: RMD) launched today its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP), combined...
Feb 07, 2024 08:05 am ET
MatrixCare Earns Three 2024 Best in KLAS Awards
MatrixCare, a global technology leader in the post-acute space, is proud to announce its Home Health and Hospice EHR solution was named Best in KLAS across multiple categories according to the 2024 Best in KLAS Software and Services report. Home...
Jan 24, 2024 04:05 pm ET
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2023. Second Quarter 2024 HighlightsAll comparisons are to the prior year period Revenue increased by 12% to $1.2 billion; up 11% on a constant currency...
Jan 03, 2024 04:05 pm ET
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2024 on Wednesday, January 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed...
Dec 27, 2023 04:05 pm ET
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer and chair of the board, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024, beginning at approximately 2:15 p.m. (Pacific...
Dec 20, 2023 04:05 pm ET
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential magnetic interference when magnets are near certain implants and medical devices in the body....
Dec 11, 2023 04:05 pm ET
ResMed Secures Significant Victory in Patent Fight Against New York University
ResMed (NYSE: RMD, ASX: RMD) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated the claims New York University (NYU) asserted against ResMed, based on seven NYU patents. In...
Dec 07, 2023 03:34 pm ET
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
ResMed (NYSE: RMD, ASX: RMD) today announced the results of a study on the global burden of Chronic Obstructive Pulmonary Disease (COPD) through 2050. Published in the Journal of the American Medical Association (JAMA) Network Open, the study found...
Nov 09, 2023 04:05 pm ET
ResMed Adopts New Operating Model to Accelerate Long-term Growth
ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated leadership in Product, Revenue, and Marketing to the global executive team. This change aims to increase...
Oct 26, 2023 04:05 pm ET
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended September 30, 2023. First Quarter 2024 HighlightsAll comparisons are to the prior year period Revenue increased by 16% to $1.1 billion; up 15% on a constant currency...
Oct 06, 2023 09:31 am ET
Thinking about trading options or stock in Apple, Super Micro Computer, Pioneer Natural Resources, Shoals Technologies Group, or Resmed?
NEW YORK, Oct. 6, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, SMCI, PXD, SHLS, and RMD.
Oct 05, 2023 04:05 pm ET
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2024 on Thursday, October 26, 2023, after the New York Stock Exchange closes. Following the release, ResMed...
Sep 05, 2023 04:05 pm ET
ResMed Announces Participation in Upcoming Conferences
ResMed (NYSE: RMD, ASX: RMD) today announced its participation in two upcoming conferences. Mick Farrell, chief executive officer and chair of the board, and Brett Sandercock, chief financial officer, will participate in a fireside chat at the...
Aug 03, 2023 04:05 pm ET
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2023. Fourth Quarter 2023 HighlightsAll comparisons are to the prior year period Revenue increased by 23% to $1.1 billion; up 23% on a constant currency...
Jul 06, 2023 04:05 pm ET
ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on Thursday, August 3, 2023, after the New York Stock Exchange closes. Following the release, ResMed...
Jul 05, 2023 04:05 pm ET
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
ResMed (NYSE: RMD, ASX: RMD) today announced the acquisition of privately held Somnoware, a U.S. leader in sleep and respiratory care diagnostics software. Somnoware software streamlines the processes of physicians as well as sleep and pulmonary...
Jun 08, 2023 09:00 am ET
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
People with heart failure and obstructive sleep apnea (OSA) can significantly reduce hospitalizations and ER visits as well as related costs by being adherent on positive airway pressure (PAP) therapy, according to two studies supported by ResMed...
Jun 05, 2023 04:05 pm ET
ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023, beginning at approximately...
May 25, 2023 09:00 am ET
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
Renowned medical experts at the American Thoracic Society International Conference unveiled new evidence that demonstrates treating obstructive sleep apnea (OSA) with positive airway pressure (PAP) therapy lowers all-cause mortality for patients....
May 02, 2023 04:05 pm ET
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
ResMed (NYSE: RMD, ASX: RMD) today announced the appointment of two new executive team members: Michael Rider, Global General Counsel & Secretary, effective July 1, 2023, and Dawn Haake as ResMed’s first Chief Quality Officer, effective May 1,...
Apr 27, 2023 04:05 pm ET
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2023. Third Quarter 2023 HighlightsAll comparisons are to the prior year period Revenue increased by 29% to $1,116.9 million; up 31% on a constant currency...
Apr 06, 2023 04:05 pm ET
ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on Thursday, April 27, 2023, after the New York Stock Exchange closes. Following the release, ResMed...
Mar 30, 2023 04:05 pm ET
ResMed Chief Administrative Officer and Global General Counsel to Retire
ResMed (NYSE: RMD, ASX: RMD) announced today that David Pendarvis, chief administrative officer, global general counsel, and secretary, plans to retire, effective June 30, 2023. He will remain in a consulting role with ResMed through December 31,...
Mar 15, 2023 04:19 pm ET
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, beginning at approximately 3:45 p.m....
Mar 13, 2023 07:00 am ET
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
ResMed (NYSE: RMD, ASX: RMD) announced today the results from its 2023 Global Sleep Survey in conjunction with National Sleep Awareness Week (March 12-18) and World Sleep Day (March 17) to raise awareness for the importance of sleep as a key...
Mar 07, 2023 09:00 am ET
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, beginning at approximately 11:20 a.m. (Eastern Daylight...
Jan 26, 2023 04:05 pm ET
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael (“Mick”) Farrell as chair of the board, effective January 25, 2023. Mr. Farrell succeeds current chair Peter Farrell who will...
Jan 26, 2023 04:05 pm ET
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2022. Second Quarter 2023 HighlightsAll comparisons are to the prior year period Revenue increased by 16% to $1,033.7 million; up 20% on a constant...
Jan 12, 2023 09:00 am ET
ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2023 on Thursday, January 26, 2023, after the New York Stock Exchange closes. Following the release, ResMed...
Jan 02, 2023 04:05 pm ET
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, beginning at approximately 1:30 p.m. (Pacific Standard Time) at the...
Nov 22, 2022 09:00 am ET
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
ResMed (NYSE: RMD, ASX: RMD) today announced it has completed its €958.6 million acquisition of MEDIFOX DAN, a German leader in software solutions for a wide variety of out-of-hospital care providers. MEDIFOX DAN is headquartered in Hildesheim,...
Oct 27, 2022 04:05 pm ET
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended September 30, 2022. First Quarter 2023 HighlightsAll comparisons are to the prior year period Revenue increased by 5% to $950.3 million; up 9% on a constant currency...
Oct 13, 2022 04:05 pm ET
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2023 on Thursday, October 27, 2022, after the New York Stock Exchange closes. Following the release, ResMed...
Sep 07, 2022 09:00 am ET
ResMed Announces Participation in the Bank of America Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference on Wednesday, September 14, 2022, beginning at approximately 9:05 a.m....
Sep 06, 2022 09:00 am ET
ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference on Monday, September 12, 2022, beginning at...
Sep 04, 2022 08:00 am ET
Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports
Over 480 million people worldwide likely suffer from chronic obstructive pulmonary disease, or COPD, according to a late-breaking abstract led by ResMed (NYSE: RMD, ASX: RMD) presented at the European Respiratory Society Congress today.1 This...
Aug 11, 2022 04:05 pm ET
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2022. Fourth Quarter 2022 HighlightsAll comparisons are to the prior year period Revenue increased by 4% to $914.7 million; up 8% on a constant currency...
Aug 02, 2022 05:00 am ET
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio
ResMed (NYSE: RMD, ASX: RMD) today announced the acquisition of Leipzig-based company mementor; the deal was completed Monday, August 1. With this acquisition, ResMed strengthens its overall sleep portfolio in Germany with a digital solution for...
Jul 14, 2022 04:05 pm ET
ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on Thursday, August 11, 2022, after the New York Stock Exchange closes. Following the release, ResMed...
Jun 28, 2022 09:00 am ET
ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care
ResMed (NYSE: RMD, ASX: RMD) today announced the promotion of Lucile Blaise to President of Sleep & Respiratory Care, effective July 1, 2022. Blaise, currently ResMed’s Vice President of Sleep & Respiratory Care for Western Europe, is a medtech...
Jun 14, 2022 02:05 am ET
ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
ResMed (NYSE: RMD, ASX: RMD) today announced a definitive agreement to acquire privately held MEDIFOX DAN, a German leader in out-of-hospital software solutions for providers in major settings across the care continuum, from Hg, a leading software...
Jun 07, 2022 09:00 am ET
ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Tuesday, June 14, 2022, beginning at approximately 1:20 p.m. (Pacific...
Jun 01, 2022 09:00 am ET
ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the William Blair Growth Stock Conference on Wednesday, June 8, 2022, beginning at approximately 9:20 a.m. (Central Daylight Time) at...
May 25, 2022 09:00 am ET
ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022, beginning at approximately 1:30 p.m. (Eastern...
May 18, 2022 04:05 pm ET
Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study
Sleep apnea sufferers can gain health benefits from PAP (positive airway pressure) treatment in as little as two hours per night, according to a study led by ResMed (NYSE: RMD, ASX: RMD) and presented at the American Thoracic Society’s annual...
May 05, 2022 04:05 pm ET
ResMed Announces Leadership Change
ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ResMed that he has accepted a new position and is leaving the company, effective immediately. Rob Douglas, President and Chief...
Apr 28, 2022 04:05 pm ET
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2022. Third Quarter 2022 HighlightsAll comparisons are to the prior year period Revenue increased by 12% to $864.5 million; up 14% on a constant currency...
Apr 27, 2022 04:05 pm ET
ResMed Announces Participation in the 24th Annual Macquarie Australia Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Tuesday, May 3, 2022, beginning at approximately 8:45 a.m. (Australian Eastern Standard Time)...
Apr 07, 2022 04:05 pm ET
ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2022 on Thursday, April 28, 2022, after the New York Stock Exchange closes. Following the release, ResMed...
Mar 17, 2022 04:05 pm ET
ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum on Tuesday, March 22, 2022, beginning at...
Mar 14, 2022 09:00 am ET
ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day
ResMed announced today the results of its 2022 Global Sleep Surveys, in conjunction with National Sleep Awareness Week (March 13-19) and World Sleep Day (March 18). The surveys, conducted in the first quarter of the year,1 asked nearly 25,000...
Mar 10, 2022 09:00 am ET
ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022, beginning at approximately 1:20 p.m. (Eastern Daylight...
Feb 16, 2022 09:00 am ET
ResMed Announces Participation in the Citi Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Citi Healthcare Conference on Wednesday, February 23, 2022, beginning at approximately 12:30 p.m. (Eastern...
Feb 01, 2022 09:00 am ET
ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer
ResMed (NYSE: RMD, ASX: RMD) today announced the appointment of Urvashi Tyagi as chief technology officer (CTO), effective today. As CTO, Tyagi will lead ResMed’s Digital Health Technology team, driving the innovation and adoption of its...
Jan 27, 2022 04:05 pm ET
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2021. Second Quarter 2022 HighlightsAll comparisons are to the prior year period Revenue increased by 12% to $894.9 million; up 13% on a constant...
Jan 06, 2022 04:05 pm ET
ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2022 on Thursday, January 27, 2022, after the New York Stock Exchange closes. Following the release, ResMed...
Jan 03, 2022 09:00 am ET
ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, beginning at approximately 1:30 p.m. (Eastern Standard Time) via...
Dec 30, 2021 09:00 am ET
ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on Thursday, January 6, 2022, beginning at approximately 4:00 p.m. (Eastern...
Nov 19, 2021 09:00 am ET
ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors
ResMed (NYSE: RMD, ASX: RMD) today announced it has elected Desney Tan and John Hernandez, both digital health leaders at world-leading tech companies, to its board of directors, during its annual stockholders’ meeting. Desney Tan is vice...
Nov 15, 2021 08:31 am ET
Thinking about trading options or stock in Riot Blockchain, AMC Entertainment, ResMed, Etsy, or Netflix?
NEW YORK, Nov. 15, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RIOT, AMC, RMD, ETSY, and NFLX.
Nov 03, 2021 09:00 am ET
ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on Wednesday, November 10, 2021, beginning at approximately 1:00...
Oct 28, 2021 04:05 pm ET
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended September 30, 2021. First Quarter 2022 HighlightsAll comparisons are to the prior year period Revenue increased by...
Oct 28, 2021 08:30 am ET
Integra LifeSciences Announces Jan De Witte as President and Chief Executive Officer
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has appointed Jan D. De Witte as its next President and Chief Executive Officer. Mr. De Witte succeeds Peter J. Arduini,...
Oct 07, 2021 04:05 pm ET
ResMed to Report First Quarter Fiscal 2022 Earnings on October 28, 2021
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2022 on Thursday, October 28, 2021, after the New York Stock Exchange closes. Following the release, ResMed...
Sep 08, 2021 09:00 am ET
ResMed Announces Participation in the Bank of America Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Bank of America Global Healthcare Conference on Wednesday, September 15, 2021, beginning at...
Sep 08, 2021 06:45 am ET
People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking ResMed-Supported ALASKA Study Presented at ERS
Using PAP (positive airway pressure) therapy as directed can significantly increase sleep apnea patients’ chances of living longer, according to a late-breaking abstract presented today at the virtual European Respiratory Society (ERS)...
Sep 02, 2021 09:00 am ET
ResMed Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9, 2021, beginning at...
Aug 25, 2021 04:15 pm ET
ResMed Announces SaaS Leadership Change
ResMed (NYSE: RMD, ASX: RMD), today announced the promotion of Bobby Ghoshal to President of ResMed’s SaaS business, effective immediately. Raj Sodhi will be leaving full-time employment at ResMed, effective September 1. Bobby has over 25 years of...
Aug 25, 2021 09:00 am ET
Supermoon Capital Launches with World's First Fund Focused on Sleep
SAN FRANCISCO, Aug. 25, 2021 /PRNewswire/ -- Supermoon Capital (www.supermooncapital.com), formerly SleepScore Ventures, launched today with its first venture fund of $36 million to invest in early-stage startups across all geographies working on science-backed innovations aimed to improve sleep. With the world's first fund investing in sleep, Supermoon Capital aims to address the rapidly emerging category of the Night Market™, the firm's name for the budding $488 billion sleep economy.
Aug 16, 2021 09:00 am ET
ResMed Launches AirSense 11 PAP Series, Advancing Digital Health in Sleep Apnea Treatment
ResMed, a global leader in digital health and sleep apnea treatment, (NYSE: RMD, ASX: RMD) today launched AirSense 11, available first in the U.S., the company’s next-generation PAP (positive airway pressure) device designed to help hundreds of...
Aug 05, 2021 04:05 pm ET
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2021
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended June 30, 2021. Fourth Quarter 2021 HighlightsAll comparisons are to the prior year period Revenue increased by 14% to $876.1...
Jul 15, 2021 04:05 pm ET
ResMed to Report Fourth Quarter Fiscal 2021 Earnings on August 5, 2021
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2021 on Thursday, August 5, 2021, after the New York Stock Exchange closes. Following the release, ResMed...
Jul 07, 2021 10:45 am ET
Thinking about trading options or stock in Daqo New Energy, Paypal, Roper Technologies, ResMed, or Oracle?
NEW YORK, July 7, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DQ, PYPL, ROP, RMD, and ORCL.
Jun 15, 2021 09:31 am ET
Thinking about trading options or stock in ResMed, Square, Roku, Virgin Galactic, or Apple?
NEW YORK, June 15, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RMD, SQ, ROKU, SPCE, and AAPL.
Jun 11, 2021 09:31 am ET
Thinking about trading options or stock in Cassava Sciences, GameStop, Adobe, ResMed, or Pfizer?
NEW YORK, June 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SAVA, GME, ADBE, RMD, and PFE.
Jun 02, 2021 09:00 am ET
ResMed Announces Participation in the Goldman Sachs 42nd Annual Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, beginning at...
May 25, 2021 04:05 pm ET
ResMed Announces Participation in the William Blair 41st Annual Growth Stock Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the William Blair 41st Annual Growth Stock Conference on Tuesday, June 1, 2021, beginning at...
May 03, 2021 10:00 am ET
Bone Health Technologies Closes $2.5 Million Funding Round and Appoints New Board Members
Bone Health Technologies, a leading innovator of technologies for improving bone health, announces today the close of its $2.5 million funding round and the appointment of three board members: Karen Drexler, MBA, Nancy Lynch, MD, MBA and Sam...
Apr 29, 2021 04:05 pm ET
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2021
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended March 31, 2021. Third Quarter 2021 HighlightsAll comparisons are to the prior year period Revenue was comparable at $768.8...
Apr 27, 2021 09:00 am ET
ResMed Announces Participation in the 23rd Annual Macquarie Australia Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Wednesday, May 5, 2021, beginning at approximately 8:45 a.m. (Australian Eastern Standard Time)...
Apr 08, 2021 04:05 pm ET
ResMed to Report Third Quarter Fiscal 2021 Earnings on April 29, 2021
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2021 on Thursday, April 29, 2021, after the New York Stock Exchange closes. Following the release, ResMed...
Mar 16, 2021 09:00 am ET
ResMed Announces Participation in KeyBanc’s Capital Markets' Life Sciences & MedTech Investor Forum
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer and Brett Sandercock, chief financial officer, will participate in a virtual fireside chat at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum on Tuesday, March 23, 2021, beginning at approximately 4:15 p.m. (Eastern Daylight Time) via video webcast.
Mar 15, 2021 09:00 am ET
New Survey Shows Stress Over the Past Year Is Negatively Impacting the Quality of Sleep for Half of Americans
ResMed (NYSE: RMD, ASX: RMD), a world-leading digital health company, announced today the results of a nationwide survey of 1,000 adults, which revealed that for half of Americans, stress over the past year is negatively impacting the quality of their sleep – and many are ignoring sleep challenges that could point to a larger underlying health concern.
Mar 15, 2021 07:30 am ET
Tactile Medical Appoints Kristie Burns as Senior Vice President of Marketing & Clinical Affairs
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, announced the appointment of Kristie Burns to the position of...
Feb 02, 2021 09:08 am ET
MatrixCare Home Health EHR Solution Wins Best in KLAS – Again
MatrixCare announced today its Home Health and Hospice EHR solution has won Best in KLAS for Home Health EHR (Large) from KLAS Research for the second year in a row.
Jan 28, 2021 04:05 pm ET
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2021
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended December 31, 2020.
Jan 07, 2021 04:05 pm ET
ResMed to Report Second Quarter Fiscal 2021 Earnings on January 28, 2021
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2021 on Thursday, January 28, 2021, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast.
Jan 05, 2021 09:00 am ET
ResMed Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, beginning at approximately 4:30 p.m. (Eastern Standard Time) via webcast.
Nov 03, 2020 09:00 am ET
ResMed Announces Participation in the Credit Suisse 29th Annual Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Credit Suisse 29th Annual Global Healthcare Conference on Tuesday, November 10, 2020, beginning at approximately 5:00 p.m. (Eastern Standard Time) via video webcast.
Oct 30, 2020 09:31 am ET
Thinking about trading options or stock in ResMed, Six Flags, Boeing, Microsoft, or Mohawk Industries?
NEW YORK, Oct. 30, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RMD, SIX, BA, MSFT, and MHK.
Oct 29, 2020 04:05 pm ET
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2021
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended September 30, 2020.
Oct 08, 2020 04:05 pm ET
ResMed to Report First Quarter Fiscal 2021 Earnings on October 29, 2020
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2021 on Thursday, October 29, 2020, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
Sep 09, 2020 09:00 am ET
ResMed Announces Participation in the Morgan Stanley 18th Annual Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Morgan Stanley 18th Annual Global Healthcare Conference on Monday, September 14, 2020, beginning at approximately 12:45 p.m. (Eastern Daylight Time) via video webcast.
Sep 01, 2020 09:00 am ET
ResMed Debuts AirTouch N20 Foam CPAP Mask, Its Softest Nasal Mask Ever
ResMed (NYSE: RMD, ASX: RMD) announced today the launch of its AirTouch N20 nasal mask, the company’s first CPAP nasal mask with a memory foam cushion and softest nasal mask ever.
Aug 26, 2020 08:00 am ET
Propeller Health Enters Japan with Digital Health Sensor for New Enerzair® and Atectura® Breezhaler® Asthma Medications
Propeller Health today announced it will begin distributing in Japan, via a collaboration with Novartis to connect the Propeller digital health platform to Enerzair® and Atectura® Breezhaler®, two new once-daily Novartis medications available outside the U.S. to treat uncontrolled asthma.
Aug 05, 2020 04:05 pm ET
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2020
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended June 30, 2020.
Jul 15, 2020 04:30 pm ET
ResMed to Report Fourth Quarter Fiscal 2020 Earnings on August 5, 2020
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2020 on Wednesday, August 5, 2020, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
Jun 03, 2020 09:00 am ET
ResMed Announces Participation in the William Blair 40th Annual Growth Stock Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the William Blair 40th Annual Growth Stock Conference on Wednesday, June 10, 2020, beginning at approximately 12:00 p.m. (Central Daylight Time) via video webcast.
May 26, 2020 08:00 am ET
Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort® Inhaler to its Digital Health Platform
Propeller Health, a leading digital health company dedicated to the management of asthma and COPD, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to connect patients using the Symbicort Inhaler to its digital health platform.
May 20, 2020 09:00 am ET
MatrixCare Celebrates Post-acute Healthcare Workers with National Heroes Program
MatrixCare is pleased to honor post-acute healthcare workers as part of the company’s “Nominate a Hero” program, an initiative launched last month to honor the committed employees working for out-of-hospital care facilities and home-based care organizations who are going above and beyond the call of duty to keep their patients and residents informed, safe, healthy, and happy amid the COVID-19 pandemic.
May 18, 2020 09:00 am ET
ResMed Debuts MaskSelector, a Digital Tool for Remote CPAP Mask Fittings
ResMed (NYSE: RMD, ASX: RMD) has launched ResMed MaskSelector, a digital tool to make remote patient mask selection and sizing easier and more effective, helping patients receive the care they need from home.
May 06, 2020 09:00 am ET
ResMed Announces Participation in the Bank of America Merrill Lynch Global Healthcare Conference
ResMed (NYSE: RMD) (ASX: RMD) today announced that Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Bank of America Securities Healthcare Conference 2020 on Tuesday, May 12, 2020, beginning at approximately 4:20 p.m. (Eastern Daylight Time) via webcast.
May 05, 2020 03:00 am ET
ResMed Accelerates Release of Ventilator Telemonitoring Platform to Enable Safer, More Efficient Patient Care
ResMed (NYSE: RMD, ASX: RMD), a world-leading digital health company, today launched cloud-based remote monitoring software for ventilators and Lumis bilevel devices across Europe, via its AirView platform.
May 01, 2020 06:20 pm ET
Company Profile for ResMed
At ResMed we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
Apr 30, 2020 04:05 pm ET
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2020
ResMed Inc. (NYSE: RMD) (ASX: RMD), a world-leading digital health company, today announced results for its quarter ended March 31, 2020.
Apr 13, 2020 11:14 am ET
Asthma Hospitalizations Dropped after Louisville Power Plants Retired Coal or Installed Better Emission Controls
After four Louisville, Kentucky, coal-fired power plants either retired coal as their energy source or installed stricter emission controls, local residents’ asthma symptoms and asthma-related hospitalizations and emergency room visits dropped dramatically, according to research published today in Nature Ener
Apr 09, 2020 04:05 pm ET
ResMed to Report Third Quarter Fiscal 2020 Earnings on April 30, 2020
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2020 on Thursday, April 30, 2020, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
Apr 02, 2020 09:58 pm ET
ResMed Statement on DPA
ResMed (NYSE: RMD, ASX: RMD) has released the following statement regarding today’s White House Memorandum on Order Under the Defense Production Act Regarding the Purch
Mar 23, 2020 04:15 pm ET
ResMed Statement on COVID-19
ResMed (NYSE: RMD) (ASX: RMD) has released the following statement from CEO Mick Farrell regarding the evolving coronavirus disease (COVID-19) outbreak:
Feb 13, 2020 04:47 pm ET
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Zuora, Arrowhead Pharmaceuticals, ResMed, and Covetrus and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of Zuora, Inc. (NYSE: ZUO), Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), ResMed, Inc. (NYSE: RMD), and Covetrus, Inc....
Feb 10, 2020 02:47 pm ET
Robbins LLP Is Investigating the Officers and Directors of ResMed Inc. (RMD) on Behalf of Shareholders
Shareholder rights law firm Robbins LLP reminds investors that it is investigating whether certain officers and directors of ResMed Inc. (NYSE: RMD) breached their fiduciary duties to shareholders. ResMed develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing.
Feb 04, 2020 07:00 am ET
Ozone Exposure Associated with Asthma Symptoms
New data from digital inhalers confirms that exposure to the air pollutant ozone is strongly linked to increased use of inhaled medications for asthma symptoms, according to a new study from CommonSpirit Health; Propeller Health; University of California, Berkeley; and University of California, San Francisco, published in
Jan 31, 2020 11:03 am ET
Brightree to Acquire Technology Provider SnapWorx, Expanding CPAP Resupply Offerings for HME Providers
Brightree announced today it has agreed to acquire privately held SnapWorx, LLC, a market-leading software company providing patient contact management and workflow optimization for the continuous positive airway pressure (CPAP) resupply market.
Jan 30, 2020 04:05 pm ET
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2020
ResMed Inc. (NYSE: RMD) (ASX: RMD), a world-leading digital health company, today announced results for its quarter ended December 31, 2019.
Jan 20, 2020 09:00 am ET
ResMed Introduces AirFit F30i, Its First Tube-up Full Face CPAP Mask
ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit F30i, its first tube-up full face CPAP mask, rounding out the most complete full face mask portfolio on the market.
Jan 17, 2020 08:52 pm ET
RESMED ALERT: Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of ResMed, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against certain officers and directors of ResMed, Inc. (NYSE: RMD) on behalf of long-term stockholders.
Jan 17, 2020 06:27 pm ET
Robbins LLP Is Investigating the Officers and Directors of ResMed Inc. (RMD) on Behalf of Shareholders
Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of ResMed Inc. (NYSE: RMD) breached their fiduciary duties to shareholders. ResMed develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing.
Jan 09, 2020 04:05 pm ET
ResMed to Report Second Quarter Fiscal 2020 Earnings on January 30, 2020
ResMed (NYSE: RMD) (ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2020 on Thursday, January 30, 2020, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
Jan 06, 2020 09:00 am ET
ResMed Announces Participation in the 38th Annual J.P. Morgan Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, chief executive officer, will present at the 38th Annual J.P. Morgan Annual Healthcare Conference on Monday, January 13, 2020, beginning at approximately 8:30 a.m. (Pacific Standard Time) at Westin St. Francis in San Francisco, CA.
Dec 13, 2019 04:15 pm ET
Globus Medical Announces Board of Director Addition and Departure
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the appointment of Robert Douglas to the Company’s Board of Directors, and the departure of Board member Kurt Wheeler, effective December 11, 2019.   Mr....
Nov 25, 2019 06:00 am ET
COPD Outcomes Improved Significantly When Patients and Doctors Used a Digital Health Tool, Propeller Health Study Finds
Patients with chronic obstructive pulmonary disease (COPD) at Louisville’s JenCare Senior Medical Center, a ChenMed company, saw their health outcomes improve significantly when their primary care physicians (PCPs) encouraged using Propeller’s digital health tool to manage their COPD, reports new research by Propeller Health, JenCare, ChenMed, and the Center for Healthy Air, Water and Soil investigators published in
Nov 19, 2019 09:00 am ET
Propeller Health Users Can Now Access Pharmacy Services From CVS, Walmart, Kroger and Rite-Aid From Within the Propeller App
Propeller Health, a leading digital health company dedicated to the management of asthma and chronic obstructive pulmonary disease (COPD), today announced that users are now able to access pharmacy services from CVS, Walmart, Kroger and Rite-Aid directly from the Propeller app.
Oct 29, 2019 09:00 am ET
Propeller Users Can Now Locate Their Lost Inhaler by “Ringing” Their Propeller Sensor From the App
Starting today, Propeller users will be able to “ring” the sensor on a misplaced inhaler to make it easier to find, through an update to the Find My Inhaler feature in the Propeller app.
Oct 29, 2019 09:00 am ET
ResMed Announces Participation in the Credit Suisse 28th Annual Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced that Rob Douglas, chief operating officer, will present at the Credit Suisse 28th Annual Healthcare Conference on Tuesday, November 12, 2019, beginning at approximately 9:10 a.m. (Mountain Standard Time) at The Phoenician in Scottsdale, AZ.
Oct 24, 2019 04:05 pm ET
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2020
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended September 30, 2019.
Oct 21, 2019 09:00 am ET
ResMed Introduces AirFit N30, World’s First Tube-Down Nasal Cradle CPAP Mask
ResMed’s lightest mask yet, AirFit N30 features an adjustable elastic headgear, plus a nasal cradle cushion that sits under the nasal bridge, eliminating soreness in that area. The mask’s curved cushion is designed to provide a secure seal regardless of how the wearer sleeps or moves.
Oct 18, 2019 09:00 am ET
New Research Reveals Updated Patient Preferences on Digital Health Technology
ResMed (NYSE: RMD, ASX: RMD) today announced results from a company-led survey, revealing new patient preferences on digital health technology. The survey highlights a reason for optimism that the markets for digital health technology will only continue to grow.
Oct 07, 2019 09:00 am ET
Cerner and ResMed Join Forces to Connect Health Networks and the Home
Cerner Corporation (NASDAQ: CERN), a global health platform and innovation company, and ResMed (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced a new collaboration agreement to help providers make more informed...
Oct 03, 2019 04:05 pm ET
ResMed to Report First Quarter Fiscal 2020 Earnings on October 24, 2019
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2020 on Thursday, October 24, 2019, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
Sep 26, 2019 09:00 am ET
ResMed to Celebrate 30th Anniversary and 20 Years Listed on the New York Stock Exchange by Ringing The Opening Bell® on September 30, 2019
ResMed (NYSE: RMD, ASX: RMD) today announced that CEO Mick Farrell will ring The Opening Bell® at the New York Stock Exchange (NYSE) on Monday, September 30, 2019 at 9:30 a.m. ET. Farrell will be joined on the bell podium with other members of the ResMed management team to celebrate 20 years of being listed on the NYSE and to commemorate ResMed’s 30th anniversary.
Sep 05, 2019 09:00 am ET
ResMed Announces Participation in the Bank of America Merrill Lynch Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced that Rob Douglas, president and chief operating officer, will present at the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, September 19, 2019, beginning at approximately 11:25 a.m. (British Summer Time) at the Bank of America Merrill Lynch Financial Centre in London.
Aug 26, 2019 09:00 am ET
ResMed Announces Participation in the 17th Annual Morgan Stanley Global Healthcare Conference
ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New York City.
Jul 25, 2019 04:05 pm ET
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended June 30, 2019.
Jul 24, 2019 10:20 am ET
60% of Referral Sources Would Switch to a Home Health and Hospice Provider that Accepts Electronic Referrals, Survey Reveals
Brightree today announced results from the first-of-its-kind survey in post-acute care, revealing a significant gap between what referring providers and health systems want, and what home health and hospice providers are delivering, when it comes to interoperability.
Jul 16, 2019 09:00 am ET
MatrixCare Appoints Geriatrician Dheeraj Mahajan as Chief Medical Officer, Executive Vice President
MatrixCare announced today that Dheeraj Mahajan, MD, MBA, MPH, FACP, CMD, CIC, CHCQM, has joined its team as chief medical officer and executive vice president to advance MatrixCare’s vision of creating a seamless continuum where data moves with...
Jul 15, 2019 04:05 pm ET
ResMed Inc. Completes $500M Private Placement Debt Offering
ResMed Inc. (NYSE: RMD, ASX: RMD) announced today the successful pricing and closing of a private placement offering of $250,000,000 principal amount 3.24% senior notes due July 10, 2026, and $250,000,000 principal amount 3.45% senior notes due July 10, 2029.
Jul 15, 2019 08:30 am ET
Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced it has further strengthened and diversified its Board with the appointments of Peter Farrell,...
Jul 09, 2019 06:30 pm ET
The Lancet Publishes: More Than 936 Million Have Obstructive Sleep Apnea Worldwide
More than 936 million people have obstructive sleep apnea – the disease’s first prevalence update in more than a decade – according to The Lancet Respiratory Medicine, the world’s leading journal in its field.
Jul 03, 2019 04:05 pm ET
ResMed to Report Fourth Quarter Fiscal 2019 Earnings on July 25, 2019
ResMed (NYSE: RMD) (ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2019 on Thursday, July 25, 2019, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
Jun 10, 2019 09:00 am ET
New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought
ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented at the annual SLEEP meeting hosted by the American Academy of Sleep Medicine (AASM) and the Sleep Research Society.
May 30, 2019 12:30 am ET
ResMed Appoints New South Asia General Manager to Help Drive Increased Awareness and Treatment of Sleep Apnea, Other Respiratory Diseases
ResMed, a world leader in connected health solutions for sleep apnea, lung disease, and other chronic diseases, today announced the appointment of Shubhi Khurana as general manager for India and South Asia.
May 28, 2019 04:05 pm ET
ResMed Announces Participation in the 40th Annual Goldman Sachs Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced that Rob Douglas, president and chief operating officer, will participate in a fireside chat discussion at the 40th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019, beginning at approximately 10:00 a.m. (Pacific Time) at the Terranea Resort in Rancho Palos Verdes, Calif.
May 23, 2019 04:05 pm ET
ResMed Announces Participation in the 39th Annual William Blair Growth Stock Conference
ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, chief executive officer, will present at the 39th Annual William Blair Growth Stock Conference on Thursday, June 6, 2019, beginning at approximately 8:40 a.m. (Central Time) at the Loews Chicago Hotel in Chicago.
May 21, 2019 09:00 am ET
ResMed Study Finds CPAP Adherence Improved by Remote Monitoring, Self-Monitoring across 3 Countries
Remote monitoring and patient self-monitoring can drive CPAP adherence for people with sleep apnea, according to research presented by ResMed (NYSE: RMD) (ASX: RMD) at the American Thoracic Society’s 2019 ATS International Conference.
May 19, 2019 03:15 pm ET
Age, Gender, Disease Severity Impact Adherence to Long-Term PAP Therapy More Than Previously Thought
ResMed (NYSE: RMD, ASX: RMD) today revealed several demographic and clinical factors affect adherence to PAP (positive airway pressure) therapy, according to a study it presented at the American Thoracic Society's ATS 2019 International Conference.
May 16, 2019 04:05 pm ET
ResMed Elects Jan De Witte to Its Board of Directors
ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital SaaS solutions, today announced it has elected experienced business executive Jan De Witte to its board of directors.
May 07, 2019 09:00 am ET
Brightree Announces Access to CommonWell Health Alliance Network for Home Health and Hospice Customers
Brightree® today announced plans for its Home Health and Hospice customers to access more than 50,000 provider locations and health systems nationwide via the CommonWell Health Alliance, a nonprofit national trade association of health IT companies, and through CommonWell to Carequality, a national, consensus-built common interoperability framework.
May 02, 2019 04:05 pm ET
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended March 31, 2019.
Apr 11, 2019 04:05 pm ET
ResMed to Report Third Quarter Fiscal 2019 Earnings on May 2, 2019
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2019 on Thursday, May 2, 2019, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
Apr 11, 2019 03:00 am ET
ResMed Introduces AirFit P30i, Its First Top-of-Head-Connected Nasal Pillows CPAP Mask
ResMed (NYSE: RMD, ASX: RMD) today introduced its second top-of-head-connected CPAP mask for treating sleep apnea, a new nasal pillows option, AirFit P30i.
Apr 10, 2019 11:47 am ET
Brightree ReSupply Solution Expands Beyond Sleep to 3 More Disease Segments
Brightree® today announced that its Brightree ReSupply solution for home medical equipment (HME) providers has expanded to support additional categories outside of sleep therapy, including incontinence, diabetic, and enteral segments.
Apr 04, 2019 09:00 am ET
Brightree Introduces First-of-its-kind Analytics Suite for HMEs
Brightree® today introduced Advanced Analytics, the first analytics platform for HMEs that highlights workflow insights, KPI tracking, and peer benchmarking, without requiring users to aggregate data themselves.
Mar 27, 2019 07:15 am ET
Investor Expectations to Drive Momentum within United Technologies, Third Point Reinsurance, Consolidated Communications, Covanta Holding, Modine Manufacturing, and ResMed — Discovering Underlying Fac
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of United Technologies Corporation (NYSE:UTX), Third Point Reinsurance Ltd....
Mar 25, 2019 09:00 am ET
ResMed Launches Next-generation ReSupply Solution
ResMed (NYSE: RMD) (ASX: RMD) today launched its automated ResMed ReSupply solution for all U.S. home medical equipment (HME) providers to increase sleep apnea patients’ long-term therapy adherence and improve patient satisfaction.
Mar 21, 2019 04:05 pm ET
ResMed to Host an Investor Meeting on April 4, 2019
ResMed (NYSE: RMD) (ASX: RMD) today announced it will host an investor meeting on Thursday, April 4th to discuss the Company’s recent acquisitions, existing joint ventures and strategy pertaining to respiratory care and out-of-hospital software.
Mar 07, 2019 05:30 pm ET
ResMed Acquires HB Healthcare to Help Millions of Koreans Living with Sleep Apnea, Other Respiratory Conditions
ResMed (NYSE: RMD, ASX: RMD), a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, today announced that is has completed the acquisition of HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions.
Mar 07, 2019 09:00 am ET
Brightree Announces Enhanced Pharmacy Suite
Brightree® today announced a new pharmacy suite for home infusion therapy providers and home medical equipment (HME) pharmacies to help them optimize business processes, more easily meet compliance requirements and provide the highest quality patient care.
Feb 28, 2019 07:10 am ET
Factors of Influence in 2019, Key Indicators and Opportunity within Franklin Resources, Heartland Express, Ameriprise Financial, Merck & Co., NGL Energy Partners LP, and ResMed — New Research Emphasiz
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Franklin Resources, Inc. (NYSE:BEN), Heartland Express, Inc....
Feb 27, 2019 09:00 am ET
MatrixCare Signs National Agreement with PharMerica for NCPDP Bidirectional and Pharmacy-Centric Order Integration
MatrixCare announced today that it has entered into a National Pharmacy Integration and Electronic Medication Administration Record (eMAR) agreement with PharMerica, a long-term care pharmacy service for senior living communities, public health...
Feb 20, 2019 09:00 am ET
ResMed and Fisher & Paykel Healthcare Announce Settlement of Global Patent Infringement Litigation
ResMed (NYSE: RMD, ASX: RMD), and Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today announced an agreement to settle all outstanding patent infringement disputes between the companies in all venues around the world.
Jan 31, 2019 08:00 am ET
A New Era in Healthcare with Digital Health: Innovest Global Inc. (OTC: IVST), eWellness Healthcare, ResMed Inc. and Progressive Care Inc.
Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at how healthcare is changing in the digital age. Investorideas recently reported on how Digital Health technologies enabling...
Jan 24, 2019 04:05 pm ET
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2019
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended December 31, 2018.
Jan 21, 2019 09:05 am ET
ResMed’s First Top-of-Head CPAP Mask, AirFit N30i, Now Available across U.S.
ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the United States, with a newly designed nasal cradle cushion that sits just under the wearer’s nose.
Jan 16, 2019 07:30 am ET
New Research Coverage Highlights Gentex, Tenneco, Mercury General, MGM Resorts International, ResMed, and Alnylam Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2019
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Gentex Corporation (NASDAQ:GNTX), Tenneco Inc. (NYSE:TEN), Mercury General...
Jan 08, 2019 09:05 am ET
Mobi Is Here: ResMed’s First Portable Oxygen Device Now Widely Available in the U.S.
ResMed (NYSE: RMD, ASX: RMD), a leader in respiratory care medical devices and out-of-hospital care software, today announced that its premier portable oxygen concentrator, Mobi, is now widely available in the United States.
Jan 07, 2019 04:05 pm ET
ResMed Completes $225 Million Acquisition of Propeller Health
ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its acquisition of Propeller Health, a digital therapeutics company providing connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and asthma.
Jan 07, 2019 03:30 pm ET
Safeguard Scientifics Partner Company Propeller Health Acquired By ResMed
RADNOR, Pa., Jan. 7, 2019 /PRNewswire/ -- Safeguard Scientifics, Inc. (NYSE: SFE) (Safeguard or the Company) today announced that its partner company, Propeller Health, has been acquired by ResMed (NYSE: RMD) (ASX: RMD) for $225 million in cash. Safeguard will receive total cash proceeds of $41.4 million, which excludes an amount of additional proceeds to be held in escrow, representing an approximate 3x cash-on-cash return and 34% IRR. Safeguard deployed $14.3 million in Propeller since August 2014 and had a 20% primary ownership position.
Jan 03, 2019 04:05 pm ET
ResMed to Report Second Quarter Fiscal 2019 Earnings on January 24, 2019
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2019 on Thursday, January 24, 2019, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
Dec 17, 2018 09:05 am ET
Brightree Acquires Mobile Delivery Provider Apacheta to Streamline HME Delivery
Brightree, a leading provider of cloud-based software helping out-of-hospital providers improve business performance and patient outcomes, today announced it has acquired privately held mobile delivery and cloud-based software-as-a-service (SaaS) provider Apacheta Corporation, further expanding the SaaS portfolio of Brightree’s owner, ResMed.
Dec 07, 2018 08:10 am ET
Detailed Research: Economic Perspectives on ResMed, Proofpoint, Southwestern Energy, Knowles, Chipotle Mexican Grill, and Medtronic — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of ResMed Inc. (NYSE:RMD), Proofpoint, Inc. (NASDAQ:PFPT), Southwestern...
Dec 03, 2018 09:05 am ET
ResMed to Acquire Propeller Health, a Leader in COPD and Asthma Connected Health Solutions, for $225 Million
ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has entered a definitive agreement to acquire Propeller Health, a digital therapeutics company providing connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and asthma.
Nov 20, 2018 09:05 am ET
ResMed Elects Harjit Gill to Its Board of Directors
ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service business solutions, today announced it has elected experienced consumer and healthcare executive Harjit Gill to its Board of Directors.
Nov 14, 2018 09:05 am ET
ResMed Completes Acquisition of MatrixCare
ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its $750 million acquisition of Minnesota-based MatrixCare, a leader in software solutions for more than 15,000 providers across skilled nursing, life plan communities, senior living and private duty.
Nov 05, 2018 09:05 am ET
ResMed to Acquire MatrixCare, Expands Out-of-Hospital SaaS Portfolio into Long-Term Care Settings
ResMed (NYSE: RMD) (ASX: RMD) today announced it has signed a definitive agreement to acquire privately held MatrixCare, a leader in U.S. long-term post-acute care software, serving more than 15,000 providers across skilled nursing, life plan communities, senior living and private duty.
Oct 30, 2018 07:55 am ET
Research Report Identifies Charter Communications, Old Dominion Freight Line, CoreLogic, Align Technology, HealthStream, and ResMed with Renewed Outlook — Fundamental Analysis, Calculating Forward Mov
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Charter Communications, Inc. (NASDAQ:CHTR), Old Dominion Freight Line,...
Oct 25, 2018 04:05 pm ET
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2019
ResMed Inc. (NYSE: RMD) (ASX: RMD), a world-leading connected health company, today announced results for its quarter ended September 30, 2018.
Oct 22, 2018 04:30 pm ET
ResMed Wins German Patent Infringement Case Against Fisher & Paykel
ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical company and innovator in sleep apnea and respiratory care, today announced the results of a court and patent office ruling in Germany in ResMed’s favor.
Oct 16, 2018 09:05 am ET
Brightree Launches First Patient App for HME
Brightree®, the leading provider of cloud-based software to help post-acute care companies improve business performance and patient outcomes, announced today from Medtrade the release of its new Patient Hub to personalize the patient experience and increase revenue for home medical equipment (HME) providers.
Oct 15, 2018 09:05 am ET
AirFit F30, ResMed’s First Minimal-Contact Full Face CPAP Mask, Now Available in the U.S., Canada
ResMed (NYSE: RMD, ASX: RMD) today announced the availability of its first minimal-contact full face CPAP mask, AirFit F30, the latest addition to its AirFit mask portfolio, which helps sleep apnea patients reduce facial marks, wear glasses in bed and curl up closer to their bed partner.
Oct 04, 2018 04:08 pm ET
ResMed to Announce First Quarter Fiscal 2019 Results
ResMed (NYSE: RMD, ASX: RMD) today announced it will report its first quarter of fiscal year 2019 results on Thursday, October 25, 2018, after the New York Stock Exchange market closes. A press release with ResMed’s results will be issued after 1:00 p.m. U.S. Pacific Time and the company will host a webcast to discuss operating results and future outlook.
Oct 04, 2018 09:05 am ET
Brightree Launches BrightreeCARE App for Home Health and Hospice Aides
Brightree®, the leading provider of cloud-based software to help post-acute care companies improve business performance and patient outcomes, announced today the release of its new BrightreeCARE app.
Sep 18, 2018 09:05 am ET
175 Million Europeans Have Sleep Apnoea, Highlighting Scale of Global Health Crisis
Roughly 175 million Europeans have obstructive sleep apnoea, according to a late-breaking abstract presented by ResMed today at the European Respiratory Society’s annual ERS Congress in Paris. Leading researchers estimate 90 million Europeans have moderate to severe sleep apnoea, meaning they experience at least 15 breathing events an hour during sleep.
Sep 13, 2018 08:00 am ET
ResMed Introduces Its First Minimal-contact Full Face CPAP Mask, AirFit F30
ResMed (NYSE: RMD) (ASX: RMD) today introduced its first minimal-contact full face CPAP mask, AirFit F30, the latest addition to its AirFit mask portfolio, which helps users reduce facial marks, wear glasses in bed and curl up closer to their bed partner.
Aug 31, 2018 04:05 pm ET
ResMed Files Patent Infringement Action against Fisher & Paykel
ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical device company and innovator in sleep apnea and respiratory care, today filed a petition with the United States International Trade Commission to stop the infringement of its patented technology by New Zealand-based medical device manufacturer Fisher & Paykel Healthcare.
Aug 27, 2018 09:05 am ET
ResMed’s Astral Life Support Ventilator Now Has AutoEPAP in U.S.
ResMed (NYSE: RMD) (ASX: RMD), a global leader in cloud-connected respiratory care devices, today announced key upgrades to its Astral life support ventilators, including Optional AutoEPAP in iVAPS for U.S. patients, a high-demand therapy option.
Aug 02, 2018 04:05 pm ET
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2018
ResMed Inc. (NYSE: RMD) (ASX: RMD) today announced results for its quarter ended June 30, 2018. Revenue for the quarter was $623.6 million, a 12 percent increase compared to the same period of the prior year.
Jul 11, 2018 09:05 am ET
ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers
ResMed (NYSE: RMD, ASX: RMD), a global leader in sleep apnea treatment and connected health solutions, and Verily, an Alphabet company, today announced their agreement to form a new joint venture.
Jul 05, 2018 04:05 pm ET
ResMed to Announce Fourth Quarter Fiscal Year 2018 Results
ResMed (NYSE: RMD, ASX: RMD) today announced it will report its fourth quarter of fiscal year 2018 results on Thursday, August 2, 2018, after the New York Stock Exchange market closes. A press release with ResMed’s results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.
Jun 18, 2018 08:30 am ET
Analysis: Positioning to Benefit within The Stars Group, AMAG Pharmaceuticals, ResMed, WestRock, Briggs & Stratton, and II-VI — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Stars Group Inc. (NASDAQ:TSG), AMAG Pharmaceuticals, Inc....
Jun 14, 2018 09:05 am ET
Brightree Announces eReferral Integration with athenahealth
Brightree, the leading provider of cloud-based software helping post-acute care companies improve business performance and patient outcomes, announced the release of a new solution that allows home medical equipment (HME) providers to digitally receive orders from more than 62,000 providers using athenaClinicals within the athenahealth ne
Jun 04, 2018 09:05 am ET
New ResMed-sponsored Study Shows Switching to Bilevel PAP Saves 56% of Patients from Therapy Termination
A new study reveals that shifting patients who are struggling with adherence to positive airway pressure (PAP) therapy to a more advanced bilevel device in the first 90 days of treatment is an effective tool for achieving adherence in well more than half of such cases.
May 31, 2018 07:00 am ET
Arcturus Announces Management Appointments; Company Founder Joseph E. Payne Reinstated as President and CEO
Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced that Dr. Peter Farrell has been named as Chairman of the Board of Directors of the Company.  Joseph E. Payne has been reinstated as President and CEO and Dr....
May 29, 2018 09:05 am ET
ResMed to Acquire HEALTHCAREfirst, a Cloud-based Software and Services Provider for Home Health and Hospice Agencies
ResMed (NYSE:RMD, ASX:RMD), a global leader in connected healthcare solutions, today announced it has entered into a definitive agreement to acquire privately held HEALTHCAREfirst, a provider of software solutions and services for home health and hospice agencies.
May 29, 2018 08:42 am ET
Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
Arcturus Therapeutics Ltd. (NASDAQ:ARCT) (“Arcturus” or the “Company), a leading RNA medicines company, today announced that, as part of a settlement agreement, it has appointed four new independent directors, Dr. Peter Farrell, Mr. Andrew Sassine,...
May 22, 2018 08:55 am ET
ResMed Studies Show Remote Monitoring and Automated Resupply Improve Adherence to PAP Therapy
Remote patient monitoring and resupply programs have been shown to improve patient adherence to positive airway pressure (PAP) therapy, according to two separate studies presented by ResMed (NYSE: RMD, ASX: RMD) this week at the ATS 2018 International Conference.
May 21, 2018 02:15 pm ET
Nearly 1 Billion People Worldwide Have Sleep Apnea, International Sleep Experts Estimate
A new data analysis presented by ResMed (NYSE: RMD, ASX: RMD) this week at the ATS 2018 International Conference indicates that the prevalence of sleep apnea impacts more than 936 million people worldwide – nearly 10 times greater than previous estimates.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.